Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DGAP-PVR : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

06/11/2021 | 04:05pm EDT
DGAP Voting Rights Announcement: QIAGEN N.V. 
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the 
objective of Europe-wide distribution 
2021-06-11 / 22:04 
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
The AFM (the Netherlands Authority For the Financial Markets) has informed us on June 9, 2021 that a notification 
related to our institution has been released by the AFM. 
The following notification has been disclosed in the relevant register on the AFM website: 
Date of transaction: 07 jun 2021 
Person obliged to notify: BlackRock, Inc. 
Issuing institution: Qiagen N.V. 
Registration Chamber of Commerce: 12036979 
Place of residence: VENLO 
Distribution in numbers 
Type of share       Number of     Number of voting    Capital       Voting      Manner of disposal      Settlement 
                    shares        rights              interest      rights 
Ordinary share      31.808.110,00 34.968.872,00       Real          Real        Indirectly - BlackRock, 
                                                                                Inc. 
Contract for        303.945,00    303.945,00          Potential     Potential   Indirectly - BlackRock, In Cash 
difference                                                                      Inc. 
Ordinary share      1.058.643,00  1.058.643,00        Potential     Potential   Indirectly - BlackRock, Physical 
                                                                                Inc.                    Delivery Distribution in percentages 
Type             Total holding Directly real Directly potential Indirectly real Indirectly potential 
Capital interest 14,37 %       0,00 %        0,00 %             13,78 %         0,59 % 
Voting rights    15,74 %       0,00 %        0,00 %             15,15 %         0,59 % 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM: https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=113490 -----------------------------------------------------------------------------------------------------------------------

2021-06-11 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      QIAGEN N.V. 
              Hulsterweg 82 
              5912 PL Venlo 
              Netherlands 
Internet:     www.qiagen.com 
 
End of News   DGAP News Service 
=------------ 

1206067 2021-06-11

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1206067&application_name=news 
 

(END) Dow Jones Newswires

June 11, 2021 16:04 ET (20:04 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL 0.80% 35116.4 Delayed Quote.14.14%
QIAGEN N.V. -0.57% 52.49 Delayed Quote.-0.11%
All news about QIAGEN N.V.
08/02DGAP-CMS : QIAGEN N.V.: Release of a capital market information
DJ
08/02QIAGEN N.V. : Release of a capital market information
EQ
08/02QIAGEN N : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS (Form 6-K)
PU
08/02QIAGEN N : Chief Financial Officer (Form 6-K)
PU
07/30QIAGEN N : Thinking about trading options or stock in Atlassian, Crispr Therapeu..
PR
07/30QIAGEN N : QIAGEN reports full results for Q2 and H1 2021
PU
07/29QIAGEN : Q2 Earnings Snapshot
AQ
07/29QIAGEN N : Earnings, Sales Jump in Q2; Reiterates FY21 Revenue Growth, EPS Guida..
MT
07/29QIAGEN N : Reports Full Results for Q2 and H1 2021
BU
07/29QIAGEN N.V. Provides Earnings Guidance for Full Year 2021
CI
More news
Financials (USD)
Sales 2021 2 136 M - -
Net income 2021 433 M - -
Net Debt 2021 727 M - -
P/E ratio 2021 27,4x
Yield 2021 -
Capitalization 12 062 M 12 062 M -
EV / Sales 2021 5,99x
EV / Sales 2022 6,20x
Nbr of Employees 5 900
Free-Float 98,2%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 52,79 $
Average target price 53,13 $
Spread / Average Target 0,63%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-0.11%12 062
MODERNA, INC.231.78%139 174
LONZA GROUP AG25.60%58 688
IQVIA HOLDINGS INC.38.03%47 386
CELLTRION, INC.-26.18%31 285
SEAGEN INC.-11.93%28 062